{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:42:02Z","timestamp":1786120922732,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD97843"],"award-info":[{"award-number":["R01HD97843"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U54MD007602"],"award-info":[{"award-number":["U54MD007602"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08348-y","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:54:55Z","timestamp":1780437295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CircRNA profiles of extracellular vesicle-enriched fractions from ART suppressed pregnant women living with HIV identifies interactome networks key to inflammation and viral latency"],"prefix":"10.1186","volume":"24","author":[{"given":"Dara","family":"Brena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandi","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina L.","family":"Badell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaun","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Dawning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaijah","family":"Bashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3230-8715","authenticated-orcid":false,"given":"Erica L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"8348_CR1","unstructured":"World Health Organization Global HIV Programme. HIV data and statistics 2022; Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics"},{"issue":"7","key":"8348_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1377\/hlthaff.2018.05391","volume":"38","author":"SS Forsythe","year":"2019","unstructured":"Forsythe SS, et al. Twenty Years Of Antiretroviral Therapy For People Living With HIV: Global Costs, Health Achievements, Economic Benefits. Health Aff (Millwood). 2019;38(7):1163\u201372.","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"8348_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1186\/s12879-020-05593-4","volume":"20","author":"F Bonnet","year":"2020","unstructured":"Bonnet F, et al. Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort. BMC Infect Dis. 2020;20(1):850.","journal-title":"BMC Infect Dis"},{"key":"8348_CR4","unstructured":"Mother-to-child transmission of HIV. World Health Organization. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/prevention\/mother-to-child-transmission-of-hiv"},{"issue":"6","key":"8348_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/QAD.0000000000003514","volume":"37","author":"CD Johnston","year":"2023","unstructured":"Johnston CD, O\u2019Brien R, Cote HCF. Inclusion of women in HIV research and clinical trials. AIDS. 2023;37(6):995\u20137.","journal-title":"AIDS"},{"key":"8348_CR6","doi-asserted-by":"publisher","first-page":"905773","DOI":"10.3389\/fimmu.2022.905773","volume":"13","author":"JA Moran","year":"2022","unstructured":"Moran JA, Turner SR, Marsden MD. Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches. Front Immunol. 2022;13:905773.","journal-title":"Front Immunol"},{"issue":"7","key":"8348_CR7","doi-asserted-by":"publisher","first-page":"e2059","DOI":"10.1093\/cid\/ciaa1928","volume":"73","author":"LF Collins","year":"2021","unstructured":"Collins LF, et al. Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2021;73(7):e2059\u201369.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"8348_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/INF.0000000000003174","volume":"40","author":"VJ Tukei","year":"2021","unstructured":"Tukei VJ, et al. Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative Women. Pediatr Infect Dis J. 2021;40(9):821\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"8348_CR9","doi-asserted-by":"publisher","first-page":"108427","DOI":"10.1016\/j.isci.2023.108427","volume":"26","author":"JF Djoba Siawaya","year":"2023","unstructured":"Djoba Siawaya JF, Maloupazoa Siawaya AC. HIV-exposed uninfected infants\u2019 immune defects: From pathogen sensing, oxidative burst to antigens responses. iScience. 2023;26(12):108427.","journal-title":"iScience"},{"issue":"3","key":"8348_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/QAD.0000000000003128","volume":"36","author":"KN Althoff","year":"2022","unstructured":"Althoff KN, et al. The shifting age distribution of people with HIV using antiretroviral therapy in the United States. AIDS. 2022;36(3):459\u201371.","journal-title":"AIDS"},{"key":"8348_CR11","doi-asserted-by":"crossref","unstructured":"Lv T, Cao W, Li T. HIV-related immune activation and inflammation: current understanding and strategies. J Immunol Res. 2021;2021:7316456.","DOI":"10.1155\/2021\/7316456"},{"key":"8348_CR12","doi-asserted-by":"crossref","unstructured":"Borrajo A. Breaking barriers to an HIV-1 cure: innovations in gene editing, immune modulation, and reservoir eradication. Life (Basel). 2025;15(2).","DOI":"10.3390\/life15020276"},{"key":"8348_CR13","doi-asserted-by":"crossref","unstructured":"Mazzuti L, Turriziani O, Mezzaroma I. The many faces of immune activation in HIV-1 infection: a multifactorial interconnection. Biomedicines. 2023;11(1).","DOI":"10.3390\/biomedicines11010159"},{"key":"8348_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.placenta.2021.09.006","volume":"115","author":"NM Ikumi","year":"2021","unstructured":"Ikumi NM, et al. Placental pathology in women with HIV. Placenta. 2021;115:27\u201336.","journal-title":"Placenta"},{"issue":"5","key":"8348_CR15","doi-asserted-by":"publisher","first-page":"e12788","DOI":"10.1111\/aji.12788","volume":"79","author":"J Jin","year":"2018","unstructured":"Jin J, Menon R. Placental exosomes: A proxy to understand pregnancy complications. Am J Reprod Immunol. 2018;79(5):e12788.","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"8348_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/COH.0000000000000694","volume":"16","author":"J Chen","year":"2021","unstructured":"Chen J, et al. Exosomes in HIV infection. Curr Opin HIV AIDS. 2021;16(5):262\u201370.","journal-title":"Curr Opin HIV AIDS"},{"key":"8348_CR17","doi-asserted-by":"publisher","first-page":"1249133","DOI":"10.3389\/fimmu.2023.1249133","volume":"14","author":"A Habib","year":"2023","unstructured":"Habib A, Liang Y, Zhu N. Exosomes multifunctional roles in HIV-1: insight into the immune regulation, vaccine development and current progress in delivery system. Front Immunol. 2023;14:1249133.","journal-title":"Front Immunol"},{"key":"8348_CR18","doi-asserted-by":"crossref","unstructured":"Czernek L, Duchler M. Exosomes as messengers between mother and fetus in pregnancy. Int J Mol Sci. 2020;21(12).","DOI":"10.3390\/ijms21124264"},{"key":"8348_CR19","doi-asserted-by":"crossref","unstructured":"Rosenfeld CS. Placenta extracellular vesicles: messengers connecting maternal and fetal systems. Biomolecules. 2024;14(8).","DOI":"10.3390\/biom14080995"},{"issue":"5","key":"8348_CR20","doi-asserted-by":"publisher","first-page":"e5021","DOI":"10.1016\/j.ajog.2019.06.010","volume":"221","author":"S Sheller-Miller","year":"2019","unstructured":"Sheller-Miller S, et al. Cyclic-recombinase-reporter mouse model to determine exosome communication and function during pregnancy. Am J Obstet Gynecol. 2019;221(5):e5021\u201350212.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"8348_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.31486\/toj.20.0049","volume":"20","author":"A Nakahara","year":"2020","unstructured":"Nakahara A, et al. Circulating Placental Extracellular Vesicles and Their Potential Roles During Pregnancy. Ochsner J. 2020;20(4):439\u201345.","journal-title":"Ochsner J"},{"key":"8348_CR22","doi-asserted-by":"publisher","first-page":"154795","DOI":"10.1016\/j.cyto.2019.154795","volume":"125","author":"P Pillay","year":"2020","unstructured":"Pillay P, et al. Exosomal Th1\/Th2 cytokines in preeclampsia and HIV-positive preeclamptic women on highly active anti-retroviral therapy. Cytokine. 2020;125:154795.","journal-title":"Cytokine"},{"key":"8348_CR23","doi-asserted-by":"crossref","unstructured":"Sun Q, et al. Regulatory roles of extracellular vesicles in pregnancy complications. J Adv Res. 2025.","DOI":"10.1016\/j.jare.2025.02.010"},{"issue":"1","key":"8348_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12977-018-0462-x","volume":"15","author":"BJ Patters","year":"2018","unstructured":"Patters BJ, Kumar S. The role of exosomal transport of viral agents in persistent HIV pathogenesis. Retrovirology. 2018;15(1):79.","journal-title":"Retrovirology"},{"issue":"1","key":"8348_CR25","doi-asserted-by":"publisher","first-page":"e0146361","DOI":"10.1371\/journal.pone.0146361","volume":"11","author":"L Moro","year":"2016","unstructured":"Moro L, et al. Placental Microparticles and MicroRNAs in Pregnant Women with Plasmodium falciparum or HIV Infection. PLoS ONE. 2016;11(1):e0146361.","journal-title":"PLoS ONE"},{"issue":"2","key":"8348_CR26","doi-asserted-by":"publisher","first-page":"e13345","DOI":"10.1111\/aji.13345","volume":"85","author":"Y Ouyang","year":"2021","unstructured":"Ouyang Y, et al. Trophoblastic extracellular vesicles and viruses: Friends or foes? Am J Reprod Immunol. 2021;85(2):e13345.","journal-title":"Am J Reprod Immunol"},{"key":"8348_CR27","doi-asserted-by":"publisher","first-page":"1376455","DOI":"10.3389\/fbioe.2024.1376455","volume":"12","author":"Z Tang","year":"2024","unstructured":"Tang Z, et al. The extracellular vesicles in HIV infection and progression: mechanisms, and theranostic implications. Front Bioeng Biotechnol. 2024;12:1376455.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"8348_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12964-022-00853-z","volume":"20","author":"M Ghafourian","year":"2022","unstructured":"Ghafourian M, et al. The implications of exosomes in pregnancy: emerging as new diagnostic markers and therapeutics targets. Cell Commun Signal. 2022;20(1):51.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"8348_CR29","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/2211-5463.12741","volume":"9","author":"Q Li","year":"2019","unstructured":"Li Q, et al. Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma. FEBS Open Bio. 2019;9(12):2052\u201362.","journal-title":"FEBS Open Bio"},{"issue":"1","key":"8348_CR30","first-page":"1","volume":"11","author":"KS Liu","year":"2019","unstructured":"Liu KS, et al. Biological functions of circular RNAs and their roles in occurrence of reproduction and gynecological diseases. Am J Transl Res. 2019;11(1):1\u201315.","journal-title":"Am J Transl Res"},{"key":"8348_CR31","doi-asserted-by":"crossref","unstructured":"Gu A, et al. Functions of circular RNA in human diseases and illnesses. Noncoding RNA. 2023;9(4).","DOI":"10.3390\/ncrna9040038"},{"issue":"1","key":"8348_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13073-024-01400-w","volume":"16","author":"J Zhao","year":"2024","unstructured":"Zhao J, et al. Circular RNA landscape in extracellular vesicles from human biofluids. Genome Med. 2024;16(1):126.","journal-title":"Genome Med"},{"key":"8348_CR33","doi-asserted-by":"publisher","first-page":"997322","DOI":"10.3389\/fgene.2022.997322","volume":"13","author":"C Guo","year":"2022","unstructured":"Guo C, et al. Circular RNAs in extracellular vesicles: Promising candidate biomarkers for schizophrenia. Front Genet. 2022;13:997322.","journal-title":"Front Genet"},{"issue":"5","key":"8348_CR34","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/infdis\/jiac501","volume":"227","author":"S Shiau","year":"2023","unstructured":"Shiau S, et al. Unique Profile of Inflammation and Immune Activation in Pregnant People With HIV in the United States. J Infect Dis. 2023;227(5):720\u201330.","journal-title":"J Infect Dis"},{"key":"8348_CR35","doi-asserted-by":"crossref","unstructured":"Willinger CM, et al. MicroRNA signature of cigarette smoking and evidence for a putative causal role of MicroRNAs in smoking-related inflammation and target organ damage. Circ Cardiovasc Genet. 2017;10(5).","DOI":"10.1161\/CIRCGENETICS.116.001678"},{"key":"8348_CR36","doi-asserted-by":"publisher","first-page":"613930","DOI":"10.3389\/fcvm.2021.613930","volume":"8","author":"WN Phoswa","year":"2021","unstructured":"Phoswa WN. The Role of HIV Infection in the Pathophysiology of Gestational Diabetes Mellitus and Hypertensive Disorders of Pregnancy. Front Cardiovasc Med. 2021;8:613930.","journal-title":"Front Cardiovasc Med"},{"key":"8348_CR37","doi-asserted-by":"crossref","unstructured":"Ariyanfar S, Good DJ. Analysis of SNHG14: a long non-coding RNA hosting SNORD116, whose loss contributes to prader-willi syndrome etiology. Genes (Basel). 2022;14(1).","DOI":"10.3390\/genes14010097"},{"issue":"6","key":"8348_CR38","doi-asserted-by":"publisher","first-page":"e13491","DOI":"10.1111\/aji.13491","volume":"86","author":"N Freitag","year":"2021","unstructured":"Freitag N, et al. Expression of the alternative splicing regulator Rbfox2 during placental development is differentially regulated in preeclampsia mouse models. Am J Reprod Immunol. 2021;86(6):e13491.","journal-title":"Am J Reprod Immunol"},{"issue":"22","key":"8348_CR39","doi-asserted-by":"publisher","first-page":"11684","DOI":"10.1093\/nar\/gks912","volume":"40","author":"L Houzet","year":"2012","unstructured":"Houzet L, et al. The extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1. Nucleic Acids Res. 2012;40(22):11684\u201396.","journal-title":"Nucleic Acids Res"},{"key":"8348_CR40","doi-asserted-by":"publisher","first-page":"1565068","DOI":"10.3389\/fimmu.2025.1565068","volume":"16","author":"II Balkan","year":"2025","unstructured":"Balkan II, et al. Longitudinal analysis of hsa-miR-3163, hsa-miR-124-3p, hsa-miR-548c-3p, and hsa-miR-27a-3p as prognostic biomarkers in HIV-infected patients. Front Immunol. 2025;16:1565068.","journal-title":"Front Immunol"},{"issue":"22","key":"8348_CR41","doi-asserted-by":"publisher","first-page":"e0151322","DOI":"10.1128\/jvi.01513-22","volume":"96","author":"Q Gao","year":"2022","unstructured":"Gao Q, et al. eIF4A3 Promotes RNA Viruses\u2019 Replication by Inhibiting Innate Immune Responses. J Virol. 2022;96(22):e0151322.","journal-title":"J Virol"},{"issue":"1","key":"8348_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12865-020-00386-5","volume":"21","author":"S Chettimada","year":"2020","unstructured":"Chettimada S, et al. Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients. BMC Immunol. 2020;21(1):57.","journal-title":"BMC Immunol"},{"key":"8348_CR43","doi-asserted-by":"publisher","first-page":"101302","DOI":"10.1016\/j.mam.2024.101302","volume":"99","author":"Z Payandeh","year":"2024","unstructured":"Payandeh Z, et al. Extracellular vesicles transport RNA between cells: Unraveling their dual role in diagnostics and therapeutics. Mol Aspects Med. 2024;99:101302.","journal-title":"Mol Aspects Med"},{"key":"8348_CR44","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1038\/srep05915","volume":"4","author":"R Reynoso","year":"2014","unstructured":"Reynoso R, et al. MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro. Sci Rep. 2014;4:5915.","journal-title":"Sci Rep"},{"key":"8348_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-13-1426-1_6","volume":"1087","author":"AC Panda","year":"2018","unstructured":"Panda AC. Circular RNAs Act as miRNA Sponges. Adv Exp Med Biol. 2018;1087:67\u201379.","journal-title":"Adv Exp Med Biol"},{"key":"8348_CR46","doi-asserted-by":"crossref","unstructured":"Maarouf M, et al. Functional involvement of circRNAs in the innate immune responses to viral infection. Viruses. 2023;15(8).","DOI":"10.3390\/v15081697"},{"key":"8348_CR47","doi-asserted-by":"crossref","unstructured":"Zucko D, et al. Circular RNA profiles in viremia and ART suppression predict competing circRNA-miRNA-mRNA networks exclusive to HIV-1 viremic patients. Viruses. 2022;14(4).","DOI":"10.3390\/v14040683"},{"key":"8348_CR48","doi-asserted-by":"crossref","unstructured":"Hokello J, et al. New insights into HIV life cycle, Th1\/Th2 shift during HIV infection and preferential virus infection of Th2 cells: implications of early HIV treatment initiation and care. Life (Basel). 2024;14(1).","DOI":"10.3390\/life14010104"},{"issue":"6","key":"8348_CR49","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/eji.201747172","volume":"48","author":"JB McBrien","year":"2018","unstructured":"McBrien JB, Kumar NA, Silvestri G. Mechanisms of CD8(+) T cell-mediated suppression of HIV\/SIV replication. Eur J Immunol. 2018;48(6):898\u2013914.","journal-title":"Eur J Immunol"},{"key":"8348_CR50","doi-asserted-by":"crossref","unstructured":"Morvan MG, et al. The CD8(+) T cell noncytotoxic antiviral responses. Microbiol Mol Biol Rev. 2021;85(2).","DOI":"10.1128\/MMBR.00155-20"},{"issue":"9","key":"8348_CR51","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1128\/JVI.02629-08","volume":"83","author":"A Tumne","year":"2009","unstructured":"Tumne A, et al. Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8\u2009+\u2009T cells. J Virol. 2009;83(9):4354\u201364.","journal-title":"J Virol"},{"issue":"1","key":"8348_CR52","doi-asserted-by":"publisher","first-page":"16356","DOI":"10.1038\/s41598-022-19970-3","volume":"12","author":"L Capa","year":"2022","unstructured":"Capa L, et al. Elite controllers long-term non progressors present improved survival and slower disease progression. Sci Rep. 2022;12(1):16356.","journal-title":"Sci Rep"},{"issue":"1","key":"8348_CR53","doi-asserted-by":"publisher","first-page":"22077","DOI":"10.1038\/s41598-020-79172-7","volume":"10","author":"Z Li","year":"2020","unstructured":"Li Z, et al. Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4(+)\/CD8(+) T cells and humoral responses in macaques. Sci Rep. 2020;10(1):22077.","journal-title":"Sci Rep"},{"key":"8348_CR54","doi-asserted-by":"publisher","first-page":"101471","DOI":"10.1016\/j.smim.2021.101471","volume":"51","author":"CW Cai","year":"2021","unstructured":"Cai CW, Sereti I. Residual immune dysfunction under antiretroviral therapy. Semin Immunol. 2021;51:101471.","journal-title":"Semin Immunol"},{"key":"8348_CR55","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fimmu.2016.00383","volume":"7","author":"B Abu-Raya","year":"2016","unstructured":"Abu-Raya B, et al. The Immune System of HIV-Exposed Uninfected Infants. Front Immunol. 2016;7:383.","journal-title":"Front Immunol"},{"key":"8348_CR56","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3389\/fimmu.2017.01461","volume":"8","author":"AJ Theron","year":"2017","unstructured":"Theron AJ, et al. The Role of Transforming Growth Factor Beta-1 in the Progression of HIV\/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders. Front Immunol. 2017;8:1461.","journal-title":"Front Immunol"},{"key":"8348_CR57","doi-asserted-by":"crossref","unstructured":"Zicari S, et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses. 2019;11(3).","DOI":"10.3390\/v11030200"},{"issue":"5","key":"8348_CR58","doi-asserted-by":"publisher","first-page":"e0027023","DOI":"10.1128\/jvi.00270-23","volume":"97","author":"LY Yim","year":"2023","unstructured":"Yim LY, et al. Transforming Growth Factor beta Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4(+) T Cells. J Virol. 2023;97(5):e0027023.","journal-title":"J Virol"},{"issue":"1","key":"8348_CR59","doi-asserted-by":"publisher","first-page":"12552","DOI":"10.1038\/s41598-019-49056-6","volume":"9","author":"S Chinnapaiyan","year":"2019","unstructured":"Chinnapaiyan S, et al. TGF-beta1 increases viral burden and promotes HIV-1 latency in primary differentiated human bronchial epithelial cells. Sci Rep. 2019;9(1):12552.","journal-title":"Sci Rep"},{"key":"8348_CR60","doi-asserted-by":"crossref","unstructured":"Cheung KW, et al. alpha(4)beta(7)(+) CD4(+) effector\/effector memory T cells differentiate into productively and latently infected central memory T cells by transforming growth factor beta1 during HIV-1 infection. J Virol. 2018;92(8).","DOI":"10.1128\/JVI.01510-17"},{"issue":"1","key":"8348_CR61","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41467-024-45555-x","volume":"15","author":"J Kim","year":"2024","unstructured":"Kim J, et al. TGF-beta blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo. Nat Commun. 2024;15(1):1348.","journal-title":"Nat Commun"},{"issue":"4","key":"8348_CR62","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/humupd\/dmae007","volume":"30","author":"M Horvat Mercnik","year":"2024","unstructured":"Horvat Mercnik M, et al. TGFbeta signalling: a nexus between inflammation, placental health and preeclampsia throughout pregnancy. Hum Reprod Update. 2024;30(4):442\u201371.","journal-title":"Hum Reprod Update"},{"key":"8348_CR63","doi-asserted-by":"crossref","unstructured":"Wen B, et al. The role of TGF-beta during pregnancy and pregnancy complications. Int J Mol Sci. 2023;24(23).","DOI":"10.3390\/ijms242316882"},{"key":"8348_CR64","doi-asserted-by":"publisher","first-page":"p2002","DOI":"10.3389\/fimmu.2017.02002","volume":"8","author":"A Weinberg","year":"2017","unstructured":"Weinberg A, et al. B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine. Front Immunol. 2017;8:p2002.","journal-title":"Front Immunol"},{"issue":"33","key":"8348_CR65","doi-asserted-by":"publisher","first-page":"E7795","DOI":"10.1073\/pnas.1803468115","volume":"115","author":"B Das","year":"2018","unstructured":"Das B, et al. Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir. Proc Natl Acad Sci U S A. 2018;115(33):E7795\u2013804.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8348_CR66","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.virol.2013.05.027","volume":"443","author":"EL Szotek","year":"2013","unstructured":"Szotek EL, Narasipura SD, Al-Harthi L. 17beta-Estradiol inhibits HIV-1 by inducing a complex formation between beta-catenin and estrogen receptor alpha on the HIV promoter to suppress HIV transcription. Virology. 2013;443(2):375\u201383.","journal-title":"Virology"},{"key":"8348_CR67","doi-asserted-by":"publisher","first-page":"879600","DOI":"10.3389\/fimmu.2022.879600","volume":"13","author":"A Kettelhut","year":"2022","unstructured":"Kettelhut A, et al. Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy. Front Immunol. 2022;13:879600.","journal-title":"Front Immunol"},{"key":"8348_CR68","doi-asserted-by":"publisher","first-page":"827717","DOI":"10.3389\/fcimb.2022.827717","volume":"12","author":"S Pasquereau","year":"2022","unstructured":"Pasquereau S, Herbein G. CounterAKTing HIV: Toward a Block and Clear Strategy? Front Cell Infect Microbiol. 2022;12:827717.","journal-title":"Front Cell Infect Microbiol"},{"key":"8348_CR69","doi-asserted-by":"crossref","unstructured":"Le Sage V, et al. Adapting the stress response: viral subversion of the mTOR signaling pathway. Viruses. 2016;8(6).","DOI":"10.3390\/v8060152"},{"key":"8348_CR70","doi-asserted-by":"publisher","first-page":"38313","DOI":"10.1038\/srep38313","volume":"6","author":"A Kumar","year":"2016","unstructured":"Kumar A, et al. Limited HIV-1 Reactivation in Resting CD4(+) T cells from Aviremic Patients under Protease Inhibitors. Sci Rep. 2016;6:38313.","journal-title":"Sci Rep"},{"key":"8348_CR71","doi-asserted-by":"publisher","first-page":"24090","DOI":"10.1038\/srep24090","volume":"6","author":"A Kumar","year":"2016","unstructured":"Kumar A, et al. Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Sci Rep. 2016;6:24090.","journal-title":"Sci Rep"},{"key":"8348_CR72","doi-asserted-by":"crossref","unstructured":"Barclay RA, et al. Extracellular vesicle activation of latent HIV-1 is driven by EV-associated c-Src and cellular SRC-1 via the PI3K\/AKT\/mTOR pathway. Viruses. 2020;12(6).","DOI":"10.3390\/v12060665"},{"issue":"8","key":"8348_CR73","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41401-024-01282-z","volume":"45","author":"JF Cai","year":"2024","unstructured":"Cai JF, et al. Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR. Acta Pharmacol Sin. 2024;45(8):1632\u201343.","journal-title":"Acta Pharmacol Sin"},{"key":"8348_CR74","doi-asserted-by":"publisher","first-page":"928210","DOI":"10.3389\/fcell.2022.928210","volume":"10","author":"J Lopez-Tello","year":"2022","unstructured":"Lopez-Tello J, et al. Ablation of PI3K-p110alpha Impairs Maternal Metabolic Adaptations to Pregnancy. Front Cell Dev Biol. 2022;10:928210.","journal-title":"Front Cell Dev Biol"},{"key":"8348_CR75","doi-asserted-by":"crossref","unstructured":"Patel M, et al. TLR4 signaling in presence of HIV-induced activation enhances programmed death ligand-1 expression on human plasmacytoid dendritic cells and modulates their function. bioRxiv; 2022: p. 2022.07.05.498853.","DOI":"10.1101\/2022.07.05.498853"},{"issue":"2","key":"8348_CR76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","volume":"36","author":"S Tartey","year":"2017","unstructured":"Tartey S, Takeuchi O. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells. Int Rev Immunol. 2017;36(2):57\u201373.","journal-title":"Int Rev Immunol"},{"key":"8348_CR77","doi-asserted-by":"crossref","unstructured":"Kayesh MEH, Kohara M, Tsukiyama-Kohara K. Toll-like receptor response to human immunodeficiency virus type 1 or co-infection with hepatitis B or C virus: an overview. Int J Mol Sci. 2023;24(11).","DOI":"10.3390\/ijms24119624"},{"issue":"10","key":"8348_CR78","doi-asserted-by":"publisher","first-page":"108485","DOI":"10.1016\/j.celrep.2020.108485","volume":"33","author":"SH Hagen","year":"2020","unstructured":"Hagen SH, et al. Heterogeneous Escape from X Chromosome Inactivation Results in Sex Differences in Type I IFN Responses at the Single Human pDC Level. Cell Rep. 2020;33(10):108485.","journal-title":"Cell Rep"},{"issue":"04","key":"8348_CR79","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4103\/2096-2924.305928","volume":"04","author":"X-R Liu","year":"2020","unstructured":"Liu X-R, et al. Toll-Like Receptor-Dependent Antiviral Responses at the Maternal-Fetal Interface. Reproductive Dev Med. 2020;04(04):251\u20136.","journal-title":"Reproductive Dev Med"},{"key":"8348_CR80","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fimmu.2018.00222","volume":"9","author":"AC Maloupazoa Siawaya","year":"2018","unstructured":"Maloupazoa Siawaya AC, et al. Altered Toll-Like Receptor-4 Response to Lipopolysaccharides in Infants Exposed to HIV-1 and Its Preventive Therapy. Front Immunol. 2018;9:222.","journal-title":"Front Immunol"},{"key":"8348_CR81","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fimmu.2020.01112","volume":"11","author":"JT Martinsen","year":"2020","unstructured":"Martinsen JT, et al. The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies. Front Immunol. 2020;11:1112.","journal-title":"Front Immunol"},{"issue":"8","key":"8348_CR82","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/QAD.0000000000002213","volume":"33","author":"LK Vibholm","year":"2019","unstructured":"Vibholm LK, et al. Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1\u2009+\u2009individuals. AIDS. 2019;33(8):1315\u201325.","journal-title":"AIDS"},{"key":"8348_CR83","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fcimb.2018.00263","volume":"8","author":"S Barichievy","year":"2018","unstructured":"Barichievy S, et al. Viral Apoptosis Evasion via the MAPK Pathway by Use of a Host Long Noncoding RNA. Front Cell Infect Microbiol. 2018;8:263.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"8348_CR84","doi-asserted-by":"publisher","first-page":"e49305","DOI":"10.15252\/embr.201949305","volume":"21","author":"X Yang","year":"2020","unstructured":"Yang X, et al. PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK\/NF-kappaB signaling. EMBO Rep. 2020;21(11):e49305.","journal-title":"EMBO Rep"},{"key":"8348_CR85","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.virusres.2018.05.028","volume":"253","author":"R Kumar","year":"2018","unstructured":"Kumar R, et al. Role of MAPK\/MNK1 signaling in virus replication. Virus Res. 2018;253:48\u201361.","journal-title":"Virus Res"},{"issue":"8","key":"8348_CR86","doi-asserted-by":"publisher","first-page":"e1007268","DOI":"10.1371\/journal.ppat.1007268","volume":"14","author":"O Chaudhary","year":"2018","unstructured":"Chaudhary O, et al. Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration. PLoS Pathog. 2018;14(8):e1007268.","journal-title":"PLoS Pathog"},{"key":"8348_CR87","doi-asserted-by":"publisher","first-page":"116950","DOI":"10.1016\/j.ejmech.2024.116950","volume":"280","author":"F Yang","year":"2024","unstructured":"Yang F, et al. The journey of p38 MAP kinase inhibitors: From bench to bedside in treating inflammatory diseases. Eur J Med Chem. 2024;280:116950.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"8348_CR88","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"8348_CR89","doi-asserted-by":"publisher","first-page":"e0136133","DOI":"10.1371\/journal.pone.0136133","volume":"10","author":"D Enderle","year":"2015","unstructured":"Enderle D, et al. Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method. PLoS ONE. 2015;10(8):e0136133.","journal-title":"PLoS ONE"},{"issue":"1","key":"8348_CR90","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1038\/s41467-024-48644-z","volume":"15","author":"C DeMarino","year":"2024","unstructured":"DeMarino C, et al. HIV-1 RNA in extracellular vesicles is associated with neurocognitive outcomes. Nat Commun. 2024;15(1):4391.","journal-title":"Nat Commun"},{"issue":"3","key":"8348_CR91","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/15592294.2021.1899887","volume":"17","author":"CG Howe","year":"2022","unstructured":"Howe CG, et al. Extracellular vesicle microRNA in early versus late pregnancy with birth outcomes in the MADRES study. Epigenetics. 2022;17(3):269\u201385.","journal-title":"Epigenetics"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08348-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:02:48Z","timestamp":1786068168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08348-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8348"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08348-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Morehouse School of Medicine IRB (#2038242-3). Written informed consents were obtained from all participants.","order":1,"name":"Ethics","label":"Ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Morehouse School of Medicine Human Research Protection Program (accredited March 2015) and adhered to the ethical principles outlined in the Belmont Report, the Declaration of Helsinki, and the Nuremberg Code, as well as applicable provisions of the Code of Federal Regulations (Titles 21 and 45). Informed consent for biospecimen collection and access to clinical data was obtained through the Study of Treatment and Reproductive Outcomes (STAR) Atlanta biorepository.","order":2,"name":"Ethics","label":"Ethic declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1008"}}